
Novartis AG
NVS
NVS: Novartis develops and manufactures healthcare products through two business segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
moreShow NVS Financials
$NVS is featured in our Shelley Moore Capito and Tom Carper strategies.
See All StrategiesRecent trades by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NVS's directors and management
Government lobbying spending instances
-
$40,000 Feb 04, 2003 Issue: Agriculture
New patents grants
Federal grants, loans, and purchases
Followers on company's Twitter account
Number of mentions of NVS in WallStreetBets Daily Discussion
Recent insights relating to NVS
Recent picks made for NVS on CNBC
ETFs with the largest estimated holdings in NVS
Flights by private jets registered to NVS